These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 36109726)

  • 1. The role of machine learning in developing non-magnetic resonance imaging based biomarkers for multiple sclerosis: a systematic review.
    Hossain MZ; Daskalaki E; Brüstle A; Desborough J; Lueck CJ; Suominen H
    BMC Med Inform Decis Mak; 2022 Sep; 22(1):242. PubMed ID: 36109726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic models for predicting clinical disease progression, worsening and activity in people with multiple sclerosis.
    Reeve K; On BI; Havla J; Burns J; Gosteli-Peter MA; Alabsawi A; Alayash Z; Götschi A; Seibold H; Mansmann U; Held U
    Cochrane Database Syst Rev; 2023 Sep; 9(9):CD013606. PubMed ID: 37681561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting disease severity in multiple sclerosis using multimodal data and machine learning.
    Andorra M; Freire A; Zubizarreta I; de Rosbo NK; Bos SD; Rinas M; Høgestøl EA; de Rodez Benavent SA; Berge T; Brune-Ingebretse S; Ivaldi F; Cellerino M; Pardini M; Vila G; Pulido-Valdeolivas I; Martinez-Lapiscina EH; Llufriu S; Saiz A; Blanco Y; Martinez-Heras E; Solana E; Bäcker-Koduah P; Behrens J; Kuchling J; Asseyer S; Scheel M; Chien C; Zimmermann H; Motamedi S; Kauer-Bonin J; Brandt A; Saez-Rodriguez J; Alexopoulos LG; Paul F; Harbo HF; Shams H; Oksenberg J; Uccelli A; Baeza-Yates R; Villoslada P
    J Neurol; 2024 Mar; 271(3):1133-1149. PubMed ID: 38133801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Machine learning applications to neuroimaging for glioma detection and classification: An artificial intelligence augmented systematic review.
    Buchlak QD; Esmaili N; Leveque JC; Bennett C; Farrokhi F; Piccardi M
    J Clin Neurosci; 2021 Jul; 89():177-198. PubMed ID: 34119265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating the feasibility of differentiating MS active lesions from inactive ones using texture analysis and machine learning methods in DWI images.
    Shekari F; Vard A; Adibi I; Danesh-Mobarhan S
    Mult Scler Relat Disord; 2024 Feb; 82():105363. PubMed ID: 38118289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnostic performance of AI-based algorithms to discriminate between NMOSD and MS using MRI features: A systematic review and meta-analysis.
    Etemadifar M; Norouzi M; Alaei SA; Karimi R; Salari M
    Mult Scler Relat Disord; 2024 Jul; 87():105682. PubMed ID: 38781885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?
    Pan YT; Lin YP; Yen HK; Yen HH; Huang CC; Hsieh HC; Janssen S; Hu MH; Lin WH; Groot OQ
    Clin Orthop Relat Res; 2024 Sep; 482(9):1710-1721. PubMed ID: 38517402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Machine learning algorithms for outcome prediction in (chemo)radiotherapy: An empirical comparison of classifiers.
    Deist TM; Dankers FJWM; Valdes G; Wijsman R; Hsu IC; Oberije C; Lustberg T; van Soest J; Hoebers F; Jochems A; El Naqa I; Wee L; Morin O; Raleigh DR; Bots W; Kaanders JH; Belderbos J; Kwint M; Solberg T; Monshouwer R; Bussink J; Dekker A; Lambin P
    Med Phys; 2018 Jul; 45(7):3449-3459. PubMed ID: 29763967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Machine Learning Approaches in Study of Multiple Sclerosis Disease Through Magnetic Resonance Images.
    Moazami F; Lefevre-Utile A; Papaloukas C; Soumelis V
    Front Immunol; 2021; 12():700582. PubMed ID: 34456913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of machine learning algorithms performance for the prediction of early multiple sclerosis from resting-state FMRI connectivity data.
    Saccà V; Sarica A; Novellino F; Barone S; Tallarico T; Filippelli E; Granata A; Chiriaco C; Bruno Bossio R; Valentino P; Quattrone A
    Brain Imaging Behav; 2019 Aug; 13(4):1103-1114. PubMed ID: 29992392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical subdomain classification of clinical notes using a machine learning-based natural language processing approach.
    Weng WH; Wagholikar KB; McCray AT; Szolovits P; Chueh HC
    BMC Med Inform Decis Mak; 2017 Dec; 17(1):155. PubMed ID: 29191207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional brain imaging: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(22):1-79. PubMed ID: 23074493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review of the application of machine-learning algorithms in multiple sclerosis.
    Vázquez-Marrufo M; Sarrias-Arrabal E; García-Torres M; Martín-Clemente R; Izquierdo G
    Neurologia (Engl Ed); 2023 Oct; 38(8):577-590. PubMed ID: 35843587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Machine learning in diagnosis and disability prediction of multiple sclerosis using optical coherence tomography.
    Montolío A; Martín-Gallego A; Cegoñino J; Orduna E; Vilades E; Garcia-Martin E; Palomar APD
    Comput Biol Med; 2021 Jun; 133():104416. PubMed ID: 33946022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic literature review on the significance of deep learning and machine learning in predicting Alzheimer's disease.
    Kaur A; Mittal M; Bhatti JS; Thareja S; Singh S
    Artif Intell Med; 2024 Aug; 154():102928. PubMed ID: 39029377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limited One-time Sampling Irregularity Map (LOTS-IM) for Automatic Unsupervised Assessment of White Matter Hyperintensities and Multiple Sclerosis Lesions in Structural Brain Magnetic Resonance Images.
    Rachmadi MF; Valdés-Hernández MDC; Li H; Guerrero R; Meijboom R; Wiseman S; Waldman A; Zhang J; Rueckert D; Wardlaw J; Komura T
    Comput Med Imaging Graph; 2020 Jan; 79():101685. PubMed ID: 31846826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artificial intelligence in the diagnosis of multiple sclerosis: A systematic review.
    Nabizadeh F; Masrouri S; Ramezannezhad E; Ghaderi A; Sharafi AM; Soraneh S; Naser Moghadasi A
    Mult Scler Relat Disord; 2022 Mar; 59():103673. PubMed ID: 35180619
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.